159724-51-3

Usage

Uses

Used in Pharmaceutical Industry:
Ethanone,1-(1H-benzimidazol-4-yl)is used as a pharmaceutical compound for its potential therapeutic applications. The benzimidazole ring is known to have various biological activities, and when combined with the ketone group, it may exhibit unique properties that can be utilized in the development of new drugs.
Used in Agrochemical Industry:
Ethanone,1-(1H-benzimidazol-4-yl)is used as an agrochemical compound for its potential applications in pest control and crop protection. Ethanone,1-(1H-benzimidazol-4-yl)-'s structure may provide a basis for the development of new pesticides or herbicides that can effectively control pests and weeds while minimizing harm to the environment.
Used in Materials Science:
Ethanone,1-(1H-benzimidazol-4-yl)is used in materials science for its potential applications in the development of new materials with unique properties. The combination of benzimidazole and ketone groups may contribute to the creation of materials with enhanced stability, conductivity, or other desirable characteristics.
It is important to handle Ethanone,1-(1H-benzimidazol-4-yl)with care and follow proper safety precautions when working with it in a laboratory or industrial setting.

Upstream product

• 1254162-48-5 1H-benzoimidazole-4-carboxylic acid N-methoxy-N-methyl-amide 
• 917-54-4 methyllithium 
• 10202-87-6 1-(3-amino-2-nitrophenyl)ethanone 

Downstream Products

• 1254162-49-6 [1-(1H-benzoimidazol-4-yl)-ethyl]-methyl-amine 

Relevant academic research and scientific papers

IMIDAZOLE DERIVATIVES AND THEIR USE AS MODULATORS OF CYCLIN DEPENDENT KINASES

The invention provides compounds of the formula (I): and salts, tautomers, solvates and N-oxides thereof; wherein Q is CH or N; X is N, N+-O- or CR3; Y is N, N+-O- or CR3a; R1 and R2 are independently selected from hydrogen and various substituents as defined in the claims; or R1 and R2 together with the atoms to which they are attached, link to form an optionally substituted carbocyclic or heterocyclic aromatic or non-aromatic ring of 4 to 7 members; R3 is selected from hydrogen and various substituents; and R3a is selected from hydrogen and various substituents as defined in the claims. Also provided are pharmaceutical compositions containing the compounds of formula (I), processes for making the compounds and the medical uses of the compounds. The compounds of formula (I) have activity as inhibitors of CDK kinases and are useful in the treatment of inter alia proliferative diseases such as cancers.

Benzimidazole compounds

The present patent application discloses compounds having the formula STR1 or a pharmaceutically acceptable salt thereof wherein R 3, R 4, R 6 and R 7 each have the meanings set forth in the specification.The compounds are useful for the treatment of various central nervous system disorders such as epilepsy and other convulsive disorders, anxiety, sleep disorders and memory disorders.

Benzimidazole useful in the treatment of central nervous system disorders

Compounds having the formula: or a pharmaceutically acceptable salt thereof, wherein, R3 is are useful for the treatment of various central nervous system disorders such as epilepsy and other convulsive disorders, anxiety, sleep disorders and memory disorders.